Innovation

Monitor of depth of anesthesia to detect and prevent awareness during general anesthesia

Drexel University
posted on 02/08/2010

The proposed product is a medical device for evaluation of the depth of anesthesia to detect and avert awareness during surgery under general anesthesia or sedation. The device is based on functional near-infrared (fNIR) technology and relies on optical techniques derived from the physical principles of light absorption and reflectance to detect changes in the hemodynamic response of the cortex to brain activation. A monitoring apparatus for objectively and continuously quantifying the depth of anesthesia of a patient during surgery would not only reduce the incidence of patient awareness, but also would allow the anesthesiologist to administer the minimal dose of anesthetic required to achieve the desired depth of anesthesia. The proposed system is intended to be utilized in any settings where sedation is given.

As many as 95 million patients annually in the United States undergo procedures for which anesthesia depth monitoring would prove useful. About 20 million of these procedures are performed under general anesthesia. While the incidence of awareness under anesthesia is small, patients who experience such awareness feel excruciating pain but cannot do anything to alert the physicians performing the procedure. Preventing awareness under anesthesia would spare the patients significant emotional and psychological problems, and reduce liability exposure to healthcare providers. The monitoring device is made of off-the-shelf components, and the fNIR probe is inexpensive and can be a disposable component of the system to be used in every general anesthesia or sedation procedure, thus providing for a very large market opportunity.

Suggested Uses

- Monitoring depth of anesthesia under general anesthesia or sedation to prevent patient awareness

- Monitoring depth of anesthesia as an aid in dosing the anesthesia to avoid overdosing to reduce associated cost of anesthetic used and accelerate recovery from anesthesia

Advantages

Unlike currently available similar devices that rely on measuring electrocardiographic (ECG), electroencephalographic (EEG), auditory and somatosensory evoked potentials, and craniofacial electromographic (EMG) signals, Drexel’s anesthesia monitor uses functional near infrared (fNIR) technology that directly measures hemodynamic parameters of brain activity associated with the effects of anesthesia.


Innovation Details
 

Detailed Description

Please see the attached executive summary for a more detailed description of the anesthesia monitor. Early work leading to the development of this monitor is summarized in the PhD thesis of one of the inventors of the monitor and is available at: http://idea.library.drexel.edu/bitst...

For further details please contact case manager on this project, Dr. Alexey Melishchuk at 215-895-0304 or am633@drexel.edu.

Thank you.

File Number: 07-0868D 

Other Information:

This device is protected by pending US and international patent applications and is available for licensing from Drexel University. For more information please contact Alexey Melishchuk at Drexel’s Office for Technology Commercialization at 215-895-0304 or am633@drexel.edu.


IP Protection

Patent Number(s): PCT/US2009/059074

License Online

This innovation currently is not available for online licensing. Please contact Alexey Melishchuk at Drexel University for more information.

Request more info via email request more info
People

Case Manager:

Alexey Melishchuk Alexey Melishchuk

Innovations (9)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

4,612 members 13,368 innovations 113 organizations

Browse

Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...